What factors are leading to growth of the Genomics industry?

Author: Rahul Palan

The future of medicine is written in our genes, and the global Genomics Market is poised for a remarkable leap forward. A recently released industry analysis by Future Market Insights (FMI) reveals that the market, valued at USD 24.3 billion in 2021, is projected to reach a staggering USD 83 billion by 2032. This translates to a significant Compound Annual Growth Rate (CAGR) of 19.8%, exceeding the historical growth rate and reflecting the immense potential of this transformative field.

Crucial information and forecast statistics covered in the Genomics market report will arm both existing and emerging market players with necessary insights to craft long-term strategies.

https://www.futuremarketinsights.com/reports/genomics-market

Following government measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.

The FMI’s report includes an interesting chapter on the preliminary impact of COVID-19 on the Genomics market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.

Genomics Market: Segmentation

Valuable information covered in the FMI’s Genomics market report has been segregated into key segments and sub-segments.

By Application:

  • Functional Genomics
    • Real-time PCR
    • Transfection
    • SNP Analysis
    • Mutational Analysis
    • Microarray Analysis
    • RNA Interference
  • Pathway Analysis
    • Microarray Analysis
    • Bead-based Analysis
    • Proteomics Tools
    • Real-time PCR
    • Mass Spectrometry
  • Biomarker Discovery
    • DNA Sequencing
    • Microarray Analysis
    • Real-time PCR
    • Mass Spectrometry
    • Other Biomarker Discoveries
  • Epigenetics
    • Bisulfite Sequencing
    • Microarray Analysis
    • Chromatin Immunoprecipitation
    • Methylated DNA Immunoprecipitation
    • Other Epigenetics
  • Other Application & Technologies

By Deliverable:

  • Products
  • Services

By End-use:

  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinics
  • Academic and Government Institutes
  • Clinical Research
  • Other End Users

Genomics Market: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Genomics market. Competitive information detailed in the Genomics market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Genomics market report.

Key players covered in the report include:

Thermo Fisher Scientific, Agilent Technologies, Beijing Genomics Institute, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., GE Healthcare, Illumina Inc., Oxford Nanopore Technologies, QIAGEN N.V., Myriad Genetics, Inc., Quest Diagnostics Incorporated, Eppendorf AG, and Eurofins Scientific